HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F M E Wagenlehner Selected Research

Tromethamine (Trometamol)

6/2017[Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline].
2/2011[National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].
1/2011[Uncomplicated urinary tract infection and treatment].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F M E Wagenlehner Research Topics

Disease

15Infections
05/2020 - 09/2002
13Urinary Tract Infections (Urinary Tract Infection)
12/2020 - 06/2002
12Prostatitis
03/2013 - 06/2003
5Pyelonephritis
12/2020 - 01/2011
5Cystitis
06/2017 - 02/2010
4Bacteriuria
04/2016 - 06/2002
3Bacterial Infections (Bacterial Infection)
05/2020 - 04/2008
3Pelvic Pain
04/2008 - 09/2007
2Sepsis (Septicemia)
04/2016 - 10/2008
2Inflammation (Inflammations)
11/2011 - 09/2007
2Cross Infection (Nosocomial Infection)
02/2008 - 08/2006
1Disease Progression
06/2022
1Epididymitis
06/2022
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
12/2018
1Coinfection
12/2018
1Schistosomiasis haematobia (Schistosomiasis haematobium)
10/2018
1Carcinogenesis
10/2018
1Carcinoma (Carcinomatosis)
10/2018
1Schistosomiasis (Bilharziasis)
10/2018
1Overactive Urinary Bladder (Overactive Bladder)
04/2016
1Bacteremia
03/2014
1Surgical Wound Infection
11/2011
1Persistent Infection
11/2011
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2006
1Communicable Diseases (Infectious Diseases)
10/2003

Drug/Important Bio-Agent (IBA)

19Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 06/2002
10FluoroquinolonesIBA
03/2014 - 03/2004
4Anti-Infective Agents (Microbicides)IBA
05/2006 - 08/2004
3Trimethoprim (Proloprim)FDA LinkGeneric
06/2017 - 02/2010
3Tromethamine (Trometamol)FDA Link
06/2017 - 01/2011
3Amdinocillin Pivoxil (Pivmecillinam)IBA
06/2017 - 01/2011
3FosfomycinFDA Link
06/2017 - 01/2011
3Nitrofurantoin (Macrodantin)FDA LinkGeneric
06/2017 - 01/2011
2Ciprofloxacin (Cipro)FDA LinkGeneric
06/2017 - 06/2002
2Levofloxacin (Levaquin)FDA Link
06/2017 - 04/2005
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
02/2011 - 02/2010
2Moxifloxacin (Avelox)FDA Link
09/2007 - 10/2006
1CefpodoximeIBA
06/2017
1Ceftibuten (Cedax)FDA Link
06/2017
1nitroxolineIBA
06/2017
1Oxygen (Dioxygen)IBA
04/2016
1Bacterial ToxinsIBA
04/2016
1ProcalcitoninIBA
03/2014
1MacrolidesIBA
11/2011
1SulfamethoxazoleFDA LinkGeneric
02/2011
1Type A Botulinum Toxins (Botox)FDA Link
09/2007
1Thymidine Monophosphate (TMP)IBA
04/2005
1Virulence Factors (Pathogenicity Factors)IBA
09/2002
1sultamicillin (ampicillin-sulbactam)FDA LinkGeneric
06/2002

Therapy/Procedure

17Therapeutics
12/2020 - 06/2003
5Catheters
06/2022 - 04/2005
2Antibiotic Prophylaxis
09/2017 - 11/2011
2Urinary Catheters
03/2013 - 06/2002
1Indwelling Catheters (Indwelling Catheter)
06/2022
1Urinary Diversion (Ileal Conduit)
06/2022
1Long-Term Care
04/2016
1Drug Therapy (Chemotherapy)
11/2011
1Secondary Prevention
10/2011
1Early Goal-Directed Therapy
10/2008
1Massage (Zone Therapy)
04/2008
1Critical Care (Surgical Intensive Care)
08/2006
1Intrauterine Devices (Intrauterine Device)
08/2003